Look Out for Potential Eye Issues With GLP-1 Agonists

August 2025

You’ll see concerns about eye problems with GLP-1 agonists.

Most GLP-1 agonist labels (dulaglutide, semaglutide, etc) already have warnings about diabetic retinopathy...where damaged or weakened blood vessels in the eye can lead to vision impairment or blindness.

Now a new study links GLP-1 agonists to neovascular (or “wet”) age-related macular degeneration (nAMD)...where abnormal blood vessels grow under the retina and leak fluid, which can lead to central vision loss.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Migraine Stay Up to Date on “New” Migraine Meds
Side Effects Look Out for Potential Eye Issues With GLP-1 Agonists
Practice Dodge the Dangers of Workplace Violence
Medication Errors Prevent MIX-Ups With Reconstituted Oral Antibiotics
ADHD Minimize Med Mishaps for Adults With ADHD
Eczema Avoid Errors With the Multitude of Topicals for Eczema
Rumor vs Truth Put Testosterone Replacement Claims to the Test
NatMed Spotlight Know the Risks of Tianeptine or “Gas Station Heroin”

Look Out for Potential Eye Issues With GLP-1 Agonists

Practical advice for a better career, with unlimited access to CE

Table of Contents